Clinical Study
Heterogeneity of Radiological Spectrum in Tacrolimus-Associated Encephalopathy after Lung Transplantation
Table 1
Clinical characteristics of 9 episodes of TAC-E of the 5 patients.
| Patient number/episode number | Age (y)/sex | Comorbidities | Clinical symptoms | Highest TAC level (ug/L) |
| 1/1 | 19/F | Mucoviscidosis, BPHT | Headache, generalized tonic-clonic seizures, and altered mental status | 11.7 | 1/2 | 19/F | Mucoviscidosis, BPHT | Confusion, epileptoid trepidation on right foot | 28.6 | 1/3 | 19/F | Mucoviscidosis, BPHT | Convulsions, coma | 4.6 | 2/4 | 14/F | Mucoviscidose BPT | Headache, diplopie, and blurred vision | 28.2 | 3/5 | 47/M | Silicosis, BPT | Myoclonus | 20.8 | 3/6 | 47/M | Silicosis, BPT | Vomiting and apathy, confusion | 18.8 | 3/7 | 47/M | Silicosis, BPT | Myoclonus, coma | NA | 4/8 | 56/F | COPD, BPT | Generalized tonic-clonic seizures with right hemiplegia, confusion | 25.1 | 5/9 | 60/M | COPD, BPT | Visual and auditory hallucinations, confusion | 22.5 |
|
|
COPD: chronic obstructive pulmonary disease; NA: not available; BPHT: bipulmonary and hepatic transplantation; BPT: bipulmonary transplantation; CPT: cardiopulmonary transplantation.
|